In double-blind, placebo-controlled trials, daily application of GHK-Cu cream at 3% concentration for 12 weeks produced a 70% increase in skin collagen thickness as measured by ultrasound imaging, a 40% increase in skin elasticity, and visible reduction in fine lines and wrinkles
AOD 9604/MOTS-c is given as a subcutaneous injection on a provider-determined schedule
Patients recovering from surgeries, especially those involving the digestive tract, should closely monitor their B12 levels
In a general weightloss setting, tesamorelin is sometimes discussed offlabel for visceral fat reduction, but any such use sits outside its primary FDA indication and should only be considered within a comprehensive medical plan, not as a cosmetic shortcut. Ready to Start a Plan That Works
Fill out a quick online form with your goals and health history